BTLA or its ligand HVEM-deficient mice were more susceptible to immune and inflammatory diseases and showed more severe pathological tissue changes, such as experimental allergic encephalomyelitis, allergic airway inflammation, and intestinal inflammation, indicating that the BTLA pathway plays a critical role in immune-inflammatory disease [18-20]. Here, BTLA is linked to gastroenteritis.